As of November 2024 Clinuvel Pharmaceuticals has 49.41M shares outstanding, a decrease of 0.00% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 49.41M | 0.00% |
2022 | 49.41M | 0.00% |
2021 | 49.41M | 0.31% |
2020 | 49.26M | - |